Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Dow
Harvard Business School
AstraZeneca
Moodys

Last Updated: September 24, 2022

IMODIUM A-D EZ CHEWS Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


When do Imodium A-d Ez Chews patents expire, and what generic alternatives are available?

Imodium A-d Ez Chews is a drug marketed by J And J Consumer Inc and is included in one NDA.

The generic ingredient in IMODIUM A-D EZ CHEWS is loperamide hydrochloride. There are eleven drug master file entries for this compound. Ninety-eight suppliers are listed for this compound. Additional details are available on the loperamide hydrochloride profile page.

Drug patent expirations by year for IMODIUM A-D EZ CHEWS
Recent Clinical Trials for IMODIUM A-D EZ CHEWS

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Naia PharmaceuticalsPhase 1/Phase 2
9 Meters Biopharma, Inc.Phase 1/Phase 2
McNeil ABPhase 1

See all IMODIUM A-D EZ CHEWS clinical trials

US Patents and Regulatory Information for IMODIUM A-D EZ CHEWS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J Consumer Inc IMODIUM A-D EZ CHEWS loperamide hydrochloride TABLET, CHEWABLE;ORAL 020448-001 Jul 24, 1997 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for IMODIUM A-D EZ CHEWS

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
J And J Consumer Inc IMODIUM A-D EZ CHEWS loperamide hydrochloride TABLET, CHEWABLE;ORAL 020448-001 Jul 24, 1997 See Plans and Pricing See Plans and Pricing
J And J Consumer Inc IMODIUM A-D EZ CHEWS loperamide hydrochloride TABLET, CHEWABLE;ORAL 020448-001 Jul 24, 1997 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for IMODIUM A-D EZ CHEWS

See the table below for patents covering IMODIUM A-D EZ CHEWS around the world.

Country Patent Number Title Estimated Expiration
Germany 69210124 See Plans and Pricing
European Patent Office 0523847 Enrobage masquant le mauvais goût pour la préparation de comprimés à mâcher pharmaceutiques (Taste mask coating for preparation of chewable pharmaceutical tablets) See Plans and Pricing
Canada 2068402 ENROBAGE POUR MASQUER LE GOUT POUVANT ETRE UTILISE DANS DES COMPRIMES PHARMACEUTIQUES CROQUABLES (TASTE MASK COATINGS FOR PREPARATION OF CHEWABLE PHARMACEUTICAL TABLETS) See Plans and Pricing
Spain 2089403 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for IMODIUM A-D EZ CHEWS

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0428296 SPC/GB98/013 United Kingdom See Plans and Pricing PRODUCT NAME: LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE; REGISTERED: UK 00242/0314 19970923
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Mallinckrodt
Express Scripts
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.